QIAGEN GENEREAD
LIVE

Serial Number

79136407

Owner

QIAGEN GMBH

Attorney

Victoria Friedman

Filing Date

Jul 12, 2013

Add to watchlist:

No watchlists yet
View on USPTO

QIAGEN GENEREAD Trademark

Serial Number: 79136407 • Registration: 4824206

QIAGEN GENEREAD is a trademark filed by QIAGEN GMBH on July 12, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

July 12, 2013

Registration Date

October 6, 2015

Published for Opposition

July 21, 2015

Cancellation Date

July 11, 2023

Goods & Services

Computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Feb 4, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 4, 2024 DETH
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 6, 2022 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 6, 2022 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 5, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 20, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 6, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 18, 2018 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 18, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 29, 2016 FICS
FINAL DISPOSITION PROCESSED
Feb 29, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 6, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2015 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Jul 17, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 1, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 1, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 1, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 16, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 16, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 16, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 16, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 16, 2015 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 20, 2015 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2015 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 4, 2015 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2014 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 18, 2014 GNFN
FINAL REFUSAL E-MAILED
Nov 18, 2014 GNFR
FINAL REFUSAL WRITTEN
Nov 18, 2014 CNFR
ASSIGNED TO LIE
Nov 18, 2014 ALIE
NEW REPRESENTATIVE AT IB RECEIVED
Aug 22, 2014 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 15, 2014 GNS3
LETTER OF SUSPENSION E-MAILED
May 15, 2014 GNSL
SUSPENSION LETTER WRITTEN
May 15, 2014 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 10, 2014 CRFA
ASSIGNED TO LIE
Apr 28, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2014 TROA
REFUSAL PROCESSED BY IB
Nov 23, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 1, 2013 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 30, 2013 RFCR
NON-FINAL ACTION WRITTEN
Oct 29, 2013 CNRT
ASSIGNED TO EXAMINER
Oct 25, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 15, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 10, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 3, 2013 REPR